Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

jennewein-biotech.de

Stage

Acquired | Acquired

Total Raised

$17.5M

Valuation

$0000 

About Jennewein Biotechnologie

Jennewein Biotechnologie is a Rheinbreitbach, Germany-based industrial biotechnology company that manufactures a portfolio of HMO products, such as 2'-fucosyllactose, 3'-fucosyllactose and lacto-N-tetraose. These rare sugars are used in the food industry (particularly infant milk formulas), the pharmaceutical industry, and the cosmetic industry.On September 22nd, 2020, Jennewein Biotechnologie was acquired by Chr. Hansen.62M.

Jennewein Biotechnologie Headquarters Location

Maarweg 32

Rheinbreitbach, 53619,

Germany

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Jennewein Biotechnologie Patents

Jennewein Biotechnologie has filed 36 patents.

The 3 most popular patent topics include:

  • Carbohydrate chemistry
  • Breastfeeding
  • EC 2.4.1
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/10/2016

8/30/2022

EC 3.2.1, Carbohydrate chemistry, EC 2.4.1, Carbohydrates, Polysaccharides

Grant

Application Date

3/10/2016

Grant Date

8/30/2022

Title

Related Topics

EC 3.2.1, Carbohydrate chemistry, EC 2.4.1, Carbohydrates, Polysaccharides

Status

Grant

Latest Jennewein Biotechnologie News

Global 6-deoxy-L-galactose Market 2021 to 2027 Industry Insights and Major Players are DuPont, Iris Biotech, Jennewein Biotechnologie, Sisco Research Laboratories

Aug 6, 2021

Home / Press Releases /Global 6-deoxy-L-galactose Market 2021 to 2027 Industry Insights and Major Players are DuPont, Iris Biotech, Jennewein Biotechnologie, Sisco Research Laboratories Global 6-deoxy-L-galactose Market 2021 to 2027 Industry Insights and Major Players are DuPont, Iris Biotech, Jennewein Biotechnologie, Sisco Research Laboratories david August 6, 2021 1 The Global 6-deoxy-L-galactose Market from 2021 to 2027 report from MarketsandResearch.biz on the latest review report offers data and fundamental measurements on market design and size. The motivation behind the examination is to give market information and key bits of knowledge that will help leaders settle on educated venture choices and recognize likely holes and development openings. Past development designs, player similar assessments, division assessments, neighbourhood assessments, and, above all, current and future propensities are totally included. Other than that, the report incorporates a blast projection for the projected year and an evaluation of the key organizations who are effectively working in this market. DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/205275 The investigation proceeds with definite admission measurements, worldwide and nearby market import and fare, deals, and gross edge examination, in addition to other things. Market division types include: Pharmaceutical Grade Coming up next are the main sellers/hierarchical leaders: DuPont, Iris Biotech, Jennewein Biotechnologie, Sisco Research Laboratories, GlycoMatrix, Sigma-Aldrich, MAK Wood, Vector Laboratories, Ardilla Technologies, Alfa Aesar This record centres on a few critical areas as far as geology: North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/205275/global-6-deoxy-l-galactose-market-2021-by-manufacturers-regions-type-and-application-forecast-to-2026 The examination gives a point by point appraisal of the current market climate, risks, and deterrents that seem to considerably affect the organization’s business innovation. By and large, the 6-deoxy-L-galactose worldwide endeavour record gives a correlation of organizations (Company benchmarking) and items (Product benchmarking) (Product benchmarking). It’s a complete manual for understanding industry elements and assembling an association that reflects them. Moreover, the 6-deoxy-L-galactose business’ expenses, production network, ware prerequisites, just as progress and limiting segments are completely thought of. Customization of the Report: This report can be customized to meet the client’s requirements. Please connect with our sales team ( sales@marketsandresearch.biz ), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements. Contact Us

  • Where is Jennewein Biotechnologie's headquarters?

    Jennewein Biotechnologie's headquarters is located at Maarweg 32, Rheinbreitbach.

  • What is Jennewein Biotechnologie's latest funding round?

    Jennewein Biotechnologie's latest funding round is Acquired.

  • How much did Jennewein Biotechnologie raise?

    Jennewein Biotechnologie raised a total of $17.5M.

  • Who are the investors of Jennewein Biotechnologie?

    Investors of Jennewein Biotechnologie include Chr. Hansen and European Investment Bank.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.